Table 1 Patients characteristics at baseline
From: Effect of volume infusion on left atrial strain in acute circulatory failure
Age - years | 59 [43–68] |
Sex male – no. (%) | 26 (68) |
BMI (kg/m2) | 24.5 [21.7–27.9] |
Comorbidities | |
Hypertension HFrEF HFpEF Paroxysmal atrial fibrillation COPD Diabetes CKD Chronic dialysis Cirrhosis Immunodepression | 17 (45%) 5 (13%) 1 (3%) 4 (11%) 2 (5%) 8 (21%) 3 (8%) 2 (5%) 8 (21%) 11 (29%) |
Chronic treatment | |
Beta-blockers ACEIs / ARBs Loop-diuretics Aldactone Amiodarone | 11 (29%) 13 (34%) 8 (21%) 3 (8%) 3 (8%) |
Reason for ICU admission | |
Acute respiratory failure Sepsis Shock Septic Cardiogenic Hypovolemic and hemorrhagic Cardiac arrest Neurologic Multidrug intoxication Other | 6 (16%) 9 (24%) 3 (8%) 2 (5%) 3 (8%) 4 (11%) 7 (19%) 2 (5%) 2 (5%) |
Severity, supports and outcomes | |
SAPS 2 on admission | 47 [35–66] |
Days of mechanical ventilation | 10 [3–14] |
Days on vasopressors / inotropes | 3 [2–7] |
ICU length of stay, days | 13 [5–21] |
Hospital length of stay, days | 23 [14–37] |
ICU mortality - no. (%) | 8 (21%) |
Hospital mortality - no. (%) | 11 (29%) |
Days from admission | 1 [0–2] |
SOFA score | 7 [4–12] |
Hemodynamic condition | |
SOFA cardio-vascular score Noradrenaline infusion – no. (%) Noradrenaline dosage – µg/kg/min Dobutamine infusion – no. (%) Dobutamine dosage – µg/kg/min Right ventricular failure – no. (%) Moderate/severe mitral or aortic valvular disease – no. (%) | 3 [1–4] 21 (55) 0.4 [0.2–0.8] 2 (5) 2.5 [2.5–2.5] 1 (3%) 1 (3%) |
Respiratory condition | |
Conventional Oxygen Therapy – no. (%) High Flow Nasal Cannula – no. (%) Non Invasive Ventilation – no. (%) Invasive Mechanical Ventilation – no. (%) PEEP – cmH2O FiO2 | 5 (13%) 3 (8%) 1 (3%) 26 (68%) 6 [5–8] 0.4 [0.3–0.6] |
Biology | |
Lactate – mmol/L [37 pts] Creatinine - µmol/L Haemoglobin – g/dL | 1.7 [1.1–4.3] 116 [81–180] 9.7 [8.6–11.1] |